Exploring Switzerland
Define the product, intended market and questions that could change your investment decision. Build an initial launch plan around the evidence you already have.
Explore this route: Exploring SwitzerlandFor international pharmaceutical businesses
Turn a Swiss market opportunity into a practical workplan. Organise regulatory, local partner, reimbursement and supply decisions before committing to launch dates or a full local affiliate.
For pharmaceutical companies, biotech teams and product owners
Choose the starting point closest to your project. You can explore the planning resources without completing a questionnaire, or contact us immediately if you already need a Swiss partner.
Define the product, intended market and questions that could change your investment decision. Build an initial launch plan around the evidence you already have.
Explore this route: Exploring SwitzerlandRecord existing approvals and dossier availability. Identify the Swiss regulatory, reimbursement and operational questions still to resolve.
Explore this route: Approved abroad, planning Swiss entryTranslate the launch plan into responsibilities, deliverables and handover points. Compare proposals against the same written scope.
Explore this route: Ready to appoint local partnersUse the evidence in context. The checklist organises your preparation; it does not assess regulatory eligibility or guarantee approval. Discuss product-specific requirements before committing to a route or launch date.
Tell us your starting point and the support you need. You can discuss the product, timing and local responsibilities in the follow-up rather than completing a long initial form.
Use the guides to organise the decisions your team needs to make.
Separate the holder, importer, quality, safety and commercial roles.
Send a short enquiry. We clarify your needs before agreeing any specialist introduction.
Start with a decision map rather than a single launch date. Identify the medicinal product, the available dossier, the target indication and the intended Swiss customer channels. An existing foreign approval is an input to route selection, not a substitute for checking the Swiss pathway. Mark assumptions explicitly so that the project team knows which dates depend on unresolved regulatory or commercial decisions.
Explore the guide →A local partner discussion is more useful when your team separates functions from company names. List the authorisation-holder role, regulatory maintenance, pharmacovigilance, quality, import, storage, distribution and customer support. Decide which capabilities you retain, which you need locally and which you want one provider to coordinate.
Explore the guide →A launch decision combines regulatory feasibility with a workable commercial and supply plan. Define your target customer channels, expected demand assumptions and the proposed reimbursement route. Separate evidence from estimates. A market-size figure alone does not establish achievable sales, and a directory of approved medicines is not a complete demand forecast.
Explore the guide →Tell us where you need support. Email, phone and a short message are enough to start; project details can follow in a conversation.
An independent information and enquiry portal. This website does not hold pharmaceutical licences or provide regulated services.